BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29367693)

  • 1. HMG-box transcription factor 1: a positive regulator of the G1/S transition through the Cyclin-CDK-CDKI molecular network in nasopharyngeal carcinoma.
    He S; Yang S; Niu M; Zhong Y; Dan Gao ; Zhang Y; Ma H; Xiong W; Zhou M; Zhou Y; Xiang B; Li G; Shuai C; Peng S
    Cell Death Dis; 2018 Jan; 9(2):100. PubMed ID: 29367693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma.
    Liu N; Tang LL; Sun Y; Cui RX; Wang HY; Huang BJ; He QM; Jiang W; Ma J
    Cancer Lett; 2013 Feb; 329(2):181-8. PubMed ID: 23142282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
    Shi J; Tan S; Song L; Song L; Wang Y
    Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-188 suppresses G1/S transition by targeting multiple cyclin/CDK complexes.
    Wu J; Lv Q; He J; Zhang H; Mei X; Cui K; Huang N; Xie W; Xu N; Zhang Y
    Cell Commun Signal; 2014 Oct; 12():66. PubMed ID: 25304455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-16 induction after CDK4 knockdown is mediated by c-Myc suppression and inhibits cell growth as well as sensitizes nasopharyngeal carcinoma cells to chemotherapy.
    Jiang Q; Zhang Y; Zhao M; Li Q; Chen R; Long X; Fang W; Liu Z
    Tumour Biol; 2016 Feb; 37(2):2425-33. PubMed ID: 26383521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of long non-coding RNA TUG1 suppresses nasopharyngeal carcinoma progression by inhibiting epithelial-mesenchymal transition (EMT) via the promotion of miR-384.
    Qian W; Ren Z; Lu X
    Biochem Biophys Res Commun; 2019 Jan; 509(1):56-63. PubMed ID: 30581000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-519 suppresses nasopharyngeal carcinoma cell proliferation by targeting oncogene URG4/URGCP.
    Yu G; Zhang T; Jing Y; Bao Q; Tang Q; Zhang Y
    Life Sci; 2017 Apr; 175():47-51. PubMed ID: 28315691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXD1, negatively regulated by miR-186, promotes the proliferation, metastasis and radioresistance of nasopharyngeal carcinoma cells.
    Zhang Y; Zhang W
    Cancer Biomark; 2020; 28(4):511-521. PubMed ID: 32568181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-214 Mediates Cell Proliferation and Apoptosis of Nasopharyngeal Carcinoma Through Targeting Both WWOX and PTEN.
    Han JB; Huang ML; Li F; Yang R; Chen SM; Tao ZZ
    Cancer Biother Radiopharm; 2020 Oct; 35(8):615-625. PubMed ID: 32101017
    [No Abstract]   [Full Text] [Related]  

  • 10. miR-539 induces cell cycle arrest in nasopharyngeal carcinoma by targeting cyclin-dependent kinase 4.
    Lv LY; Wang YZ; Zhang Q; Zang HR; Wang XJ
    Cell Biochem Funct; 2015 Dec; 33(8):534-40. PubMed ID: 26559153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of c-Myc inhibits cell proliferation by negatively regulating the Cdk/Rb/E2F pathway in nasopharyngeal carcinoma cells.
    Niu Z; Liu H; Zhou M; Wang H; Liu Y; Li X; Xiong W; Ma J; Li X; Li G
    Acta Biochim Biophys Sin (Shanghai); 2015 Mar; 47(3):183-91. PubMed ID: 25630654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MircoRNA-629 promotes proliferation, invasion and migration of nasopharyngeal carcinoma through targeting PDCD4.
    Zheng YQ; Bai YF; Yang S; Cui YR; Wang YP; Hu WL
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):207-216. PubMed ID: 30657562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA ZFAS1 promotes tumorigenesis and metastasis in nasopharyngeal carcinoma by sponging miR-892b to up-regulate LPAR1 expression.
    Peng J; Liu F; Zheng H; Wu Q; Liu S
    J Cell Mol Med; 2020 Jan; 24(2):1437-1450. PubMed ID: 31851778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-coded miR-BART13 promotes nasopharyngeal carcinoma cell growth and metastasis via targeting of the NKIRAS2/NF-κB pathway.
    Xu YJ; Zhou R; Zong JF; Lin WS; Tong S; Guo QJ; Lin C; Lin SJ; Chen YX; Chen MR; Chen HL; Ye YB; Pan JJ
    Cancer Lett; 2019 Apr; 447():33-40. PubMed ID: 30684592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [siRNA-mediated CDK6 knockdown suppresses nasopharyngeal carcinoma cell growth and cell cycle transition in vitro].
    Luo X; Xia Q; Qin J; Huang Y; Liu J; Wang Y; Wang H; Chen J
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jun; 34(7):1071-4. PubMed ID: 25057088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells.
    Cui Z; Zhao Y
    BMC Cancer; 2019 Jan; 19(1):104. PubMed ID: 30678643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDK4 and miR-15a comprise an abnormal automodulatory feedback loop stimulating the pathogenesis and inducing chemotherapy resistance in nasopharyngeal carcinoma.
    Liu Z; Cheng C; Luo X; Xia Q; Zhang Y; Long X; Jiang Q; Fang W
    BMC Cancer; 2016 Mar; 16():238. PubMed ID: 26993269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA TGFBR2 acts as a ceRNA to suppress nasopharyngeal carcinoma progression by sponging miR-107.
    Li W; Lu H; Wang H; Ning X; Liu Q; Zhang H; Liu Z; Wang J; Zhao W; Gu Y; Li H; Sun X; Hu L; Wang D
    Cancer Lett; 2021 Feb; 499():301-313. PubMed ID: 33160003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of lncRNA X Inactive Specific Transcript (XIST) Suppresses Cell Proliferation and Enhances Radiosensitivity by Upregulating mir-29c in Nasopharyngeal Carcinoma Cells.
    Han Q; Li L; Liang H; Li Y; Xie J; Wang Z
    Med Sci Monit; 2017 Oct; 23():4798-4807. PubMed ID: 28985197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA circRNF13 inhibits proliferation and metastasis of nasopharyngeal carcinoma via SUMO2.
    Mo Y; Wang Y; Zhang S; Xiong F; Yan Q; Jiang X; Deng X; Wang Y; Fan C; Tang L; Zhang S; Gong Z; Wang F; Liao Q; Guo C; Li Y; Li X; Li G; Zeng Z; Xiong W
    Mol Cancer; 2021 Aug; 20(1):112. PubMed ID: 34465340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.